THIER Appoints Hazel Owen as Independent Non-Executive Director to Strengthen Legal and Strategic Oversight in Healthcare
THIER Appoints Hazel Owen as Independent Non-Executive Director to Strengthen Legal and Strategic Oversight in Healthcare
THIER Appoints Hazel Owen as Independent Non-Executive Director to Strengthen Legal and Strategic Oversight in Healthcare ⚖️
THIER, an emerging digital health start-up focused on preventing lifestyle diseases 🏥, is pleased to announce the appointment of Hazel Owen as an Independent Non-Executive Director, effective September 25, 2024. Hazel’s addition to the board is set to enhance THIER’s strategic oversight, with her extensive legal expertise in healthcare and health-tech sectors contributing a unique perspective to the company’s growth strategy 📈.
Hazel Owen brings over 15 years of legal experience, with a strong foundation in complex commercial and litigation matters ⚖️. Starting her career in insurance and private practice, Hazel quickly distinguished herself as a skilled litigator and commercial lawyer. For the last 15 years, she has served as an in-house lawyer within the National Health Service (NHS) 🏥, where she handled high-profile cases and managed sensitive legal issues across litigation and commercial domains. This role provided Hazel with a deep understanding of healthcare’s regulatory and operational frameworks, enabling her to address high-stakes situations with discretion and strategic acumen.
In 2022, Hazel transitioned to the health-tech sector, joining ZAVA, a leading health-tech company, as sole counsel responsible for multi-jurisdictional legal operations 🌐 in a rapidly evolving environment. Her role has involved close collaboration with executive teams and the board, influencing critical decisions and advising on risk management strategies. Hazel’s broad skill set in both technical legal issues and boardroom decision-making aligns well with THIER’s mission to provide AI-driven solutions for health and wellness 🤖🌱.
Kofo Mary Are, Senior Executive at THIER, shared:
"We are thrilled to welcome Hazel Owen to the THIER Board. Hazel’s extensive legal experience in healthcare and health-tech will be invaluable as we navigate the complexities of our industry. Her insights and strategic approach to legal and risk management will play a crucial role in supporting THIER’s growth." 🤝✨
Hazel Owen shared:
"I am honoured to join THIER’s board and contribute to its innovative mission in digital health. I look forward to working with the team to shape impactful strategies that support wellness and prevent lifestyle diseases." 🌍
About THIER
THIER is an AI-enabled mobile platform 🤖📱 designed to prevent obesity and type II diabetes by empowering organizations to create healthier workplace environments 🌿.
Focused on Heads of Wellness, Heads of HR, and Heads of Occupational Health, THIER provides actionable tools to identify, monitor, and prevent the onset of lifestyle diseases within employee populations across industries, including:
- Manufacturing 🏭
- Healthcare 🏥
- Technology 💻
- Financial Services 💰
- Energy ⚡
- Transportation 🚛
The platform leverages machine learning algorithms 🧠, community engagement 🤝, and personalised interventions from preventive healthcare professionals 🩺, all supported by secure blockchain technology 🔒 to protect user data.
Learn more about THIER’s groundbreaking approach:
- 🌐 Visit our website: www.thier.io
- 🎥 Watch our introductory video: https://shorturl.at/VzJJr
🤝 Interested in supporting early-stage digital health innovation as an investor? Connect with us here: https://shorturl.at/c5YbT
💡 Note: THIER holds SEIS and EIS assurance, providing tax benefits for eligible investors.
Contact Information:
📧 THIER Communications Team: Press@Thier.io
***********
The information in this announcement may include forward-looking statements, which are based on the current expectations and projections about future events, and in certain cases can be identified by the use of terms such as "may","will", "should", "expect","anticipate", "project", "estimate","intend", "continue", "target","believe" (or the negatives thereon) or other variations thereon or comparable terminology.
These forward-looking statements, as well as those included in any related materials, are subject to risks, uncertainties and assumptions about the Company and/or its underlying investments, including, among other things, the development of the applicable entity's business, trends in its operating industry, expected use of financing proceeds and future capital expenditures and acquisitions. Considering these risks, uncertainties and assumptions, the events in the forward-looking statements may not occur.
The information contained in this announcement is given at the date of its publication (unless otherwise marked). No reliance may be placed for any purpose whatsoever on the information or opinions contained in this announcement or on its completeness, accuracy or fairness.
